JPMorgan analyst Judah Sokel downgraded BrightView Holdings to Neutral from Overweight with an unchanged $18 price target. The analyst remains positive on the company's longer term potential, but he sees risk to estimates and prefers moving to the sidelines after the stock's year-to-date run of 75%. He's cautious in the near-term about BrightView's fiscal Q3 results. A strong May rain season likely created a challenging environment for maintenance ancillary work and development projects, Sokel tells investors in a research note. He also senses a possible secondary on the horizon following the company's recent shelf registration.